Johnson & Johnson - 53 Year Dividend History | JNJ

Historical dividend payout and yield for Johnson & Johnson (JNJ) since 1972. The current TTM dividend payout for Johnson & Johnson (JNJ) as of July 03, 2025 is $5.20. The current dividend yield for Johnson & Johnson as of July 03, 2025 is 3.33%.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $375.371B $88.821B
Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. The company has several drugs covering a broad range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. The Medical Devices Segment offers products in the orthopedics, surgery, interventional solutions and vision markets. The Consumer Segment segment includes a broad range of products covering the areas of baby care, beauty/skin health, oral care, wound care and womens' health care, as well as over-the-counter (OTC) pharmaceutical products.
Stock Name Country Market Cap PE Ratio
Eli Lilly (LLY) United States $739.869B 56.74
AbbVie (ABBV) United States $334.345B 18.43
Novo Nordisk (NVO) Denmark $308.844B 20.46
Roche Holding AG (RHHBY) Switzerland $257.924B 0.00
Novartis AG (NVS) Switzerland $257.504B 14.70
Merck (MRK) United States $203.218B 10.39
Pfizer (PFE) United States $144.295B 7.91
Sanofi (SNY) France $118.454B 11.67
Bayer (BAYRY) Germany $30.141B 6.14
Innoviva (INVA) United States $1.206B 12.64